Androgens and erythropoiesis. 3. Further evaluation of testosterone treatment of myelofibrosis.
D000368:Aged; D000469:Alkaline Phosphatase; D002859:Chromium Isotopes; D004920:Erythropoiesis / Q000187:drug effects*; D005260:Female; D006073:Gout / Q000209:etiology; D006400:Hematocrit; D006454:Hemoglobins; D006801:Humans; D007501:Iron / Q000378:metabolism; D007503:Iron Isotopes; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D013163:Splenomegaly / Q000209:etiology; D013739:Testosterone / Q000009:adverse effects / Q000627:therapeutic use*
D002859:Chromium Isotopes; D006454:Hemoglobins; D007503:Iron Isotopes; D013739:Testosterone; D007501:Iron; D000469:Alkaline Phosphatase